PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery

BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
Shanshan GuYongchao Zhao

Abstract

Proteolysis-targeting chimeric molecules (PROTACs) represent an emerging technique that is receiving much attention for therapeutic intervention. The mechanism is based on the inhibition of protein function by hijacking a ubiquitin E3 ligase for protein degradation. The hetero-bifunctional PROTACs contain a ligand for recruiting an E3 ligase, a linker, and another ligand to bind with the protein targeted for degradation. Thus, PROTACs have profound potential to eliminate "undruggable" protein targets, such as transcription factors and non-enzymatic proteins, which are not limited to physiological substrates of the ubiquitin-proteasome system. These findings indicate great prospects for PROTACs in the development of therapeutics. However, there are several limitations related to poor stability, biodistribution, and penetrability in vivo. This review provides an overview of the main PROTAC-based approaches that have been developed and discusses the promising opportunities and considerations for the application of this technology in therapies and drug discovery.

References

Oct 6, 1998·Annual Review of Biochemistry·A Hershko, A Ciechanover
Jun 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·C T RollinsT Clackson
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·K M SakamotoR J Deshaies
Nov 22, 2001·Journal of the National Cancer Institute·M E GrossmannD J Tindall
Oct 4, 2003·Molecular & Cellular Proteomics : MCP·Kathleen M SakamotoRaymond J Deshaies
Jan 6, 2004·Science·Lyubomir T VassilevEmily A Liu
Mar 25, 2004·Journal of the American Chemical Society·John S SchneeklothCraig M Crews
Feb 22, 2005·Advanced Drug Delivery Reviews·Hilary BrooksEric Vivès
May 3, 2005·Nature Reviews. Cancer·Nancy E Hynes, Heidi A Lane
May 10, 2006·RNA·Yuriy FedorovAnastasia Khvorova
Jul 19, 2006·Nature Reviews. Genetics·Jeffrey A EngelmanLewis C Cantley
Jul 3, 2007·Cell·Brendan D Manning, Lewis C Cantley
Dec 14, 2007·Nature·James A Wells, Christopher L McClendon
Jan 31, 2008·The Journal of Biological Chemistry·Keiko SekineMikihiko Naito
Aug 30, 2008·Bioorganic & Medicinal Chemistry Letters·Ashley R SchneeklothCraig M Crews
Mar 13, 2010·Science·Takumi ItoHiroshi Handa
Aug 5, 2011·Nature·Johannes ZuberChristopher R Vakoc
Jun 5, 2012·Bioorganic & Medicinal Chemistry Letters·Yukihiro ItohYuichi Hashimoto
Jun 23, 2012·Nature Reviews. Cancer·Anna C Belkina, Gerald V Denis
Jul 13, 2012·Nature Reviews. Cancer·Yosef Yarden, Gur Pines
Nov 16, 2012·Current Pharmaceutical Design·Yongchao Zhao, Yi Sun
Jan 5, 2013·Science·Le CongFeng Zhang
May 15, 2013·FEBS Letters·Chérine Bechara, Sandrine Sagan
May 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·John HinesCraig M Crews
Jun 7, 2014·Molecular Cell·Junwei Shi, Christopher R Vakoc
Oct 12, 2014·Biochemical and Biophysical Research Communications·Kristopher Montrose, Geoffrey W Krissansen
Jun 3, 2015·ACS Chemical Biology·Michael ZengerleAlessio Ciulli
Jun 9, 2015·Chemistry & Biology·Jing LuCraig M Crews
Jun 16, 2015·Nature Chemical Biology·Daniel P BondesonCraig M Crews
Jan 13, 2016·Angewandte Chemie·Momar Toure, Craig M Crews

❮ Previous
Next ❯

Citations

Aug 28, 2018·Expert Opinion on Drug Discovery·Ashok VaidyaRathnam Chaguturu
Jan 4, 2019·Cell Biochemistry and Function·Yutian ZouYinyin Wang
Feb 2, 2019·Future Medicinal Chemistry·Jianguo Qi, Gang Zhang
Feb 14, 2019·Chemical Communications : Chem Comm·Bosheng Zhao, Kevin Burgess
Sep 25, 2018·Current Drug Targets·Lidong Wang, Ruijun Zhang
Jun 4, 2019·Proceedings of the National Academy of Sciences of the United States of America·Huiyin LanYi Sun
Nov 9, 2019·Future Medicinal Chemistry·Li-Wen XiaYong-Tao Duan
Nov 8, 2019·Blood·Katie A FennellMark A Dawson
Jun 19, 2019·Current Topics in Medicinal Chemistry·Yongtao DuanChuanjun Song
Oct 12, 2019·Nature Reviews. Drug Discovery·Soufiane Boumahdi, Frederic J de Sauvage
Aug 29, 2018·The AAPS Journal·Prabhakar BastolaJeremy Chien
Dec 31, 2019·Signal Transduction and Targeted Therapy·Xiuyun SunYu Rao
Jun 21, 2020·International Journal of Molecular Sciences·Iris Z UrasEmilio Casanova
Jun 14, 2019·Molecular Carcinogenesis·Rachel M SammonsKevin N Dalby
Jan 11, 2020·Future Medicinal Chemistry·Jarod M Waybright, Lindsey I James
Jul 1, 2020·Frontiers in Chemistry·Karen A Sap, Eric A Reits
Mar 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Isobel Tibbetts, George E Kostakis
Sep 17, 2020·Cell Death & Disease·Monika ŠtětkováStjepan Uldrijan
Jun 27, 2019·Molecular Neurobiology·R VelazquezTravis Dunckley
Jan 15, 2021·Clinical Science·Md Ezazul HaqueDong-Kug Choi
Nov 4, 2020·European Journal of Medicinal Chemistry·Lisha WangBengt Winblad
Feb 23, 2020·Acta Pharmaceutica Sinica. B·Yang WangHaopeng Sun
Apr 15, 2020·Cancer Cell·Matthias Drosten, Mariano Barbacid
Feb 6, 2021·Biochemical Society Transactions·Yang CaoLin Wang
Dec 29, 2020·Medicinal Research Reviews·Fanwang MengCheng Luo
Mar 12, 2021·Bioorganic Chemistry·Mengzhu ZhengHua Li
Jul 25, 2020·European Journal of Medicinal Chemistry·Brilliant N MarakVed Prakash Singh
Mar 26, 2021·European Journal of Medicinal Chemistry·Zheng ZhangTingting Liu
Sep 2, 2020·Biochimica Et Biophysica Acta. Proteins and Proteomics·Shelton R BoydDamian W Young
Mar 30, 2021·EMBO Reports·Kevin G Mark, Michael Rape
Sep 1, 2020·Biochemical Pharmacology·Yuqing LiangKui Cheng
Apr 20, 2021·Expert Opinion on Drug Discovery·Kayla Farrell, Timothy J Jarome
Jun 21, 2021·Signal Transduction and Targeted Therapy·Chenya ZhuoMingqiang Li
Jun 28, 2021·Bioorganic Chemistry·Chao WangRenshuai Zhang
Jul 10, 2021·Angewandte Chemie·Shipeng HeChunquan Sheng
Aug 29, 2019·ACS Chemical Biology·Hannah TovellDario R Alessi
Aug 24, 2018·ACS Chemical Biology·Kristin M RichingDanette L Daniels
Jan 15, 2019·Biochemistry·Soumyashree A GangopadhyayAmit Choudhary

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.